Zeliha joined QPS in July 2017 as Director of Business Development. She is presently responsible for client services in the early phase clinical services area.Zeliha joined the CRO business in 2015 when she started working for Julius Clinical where she worked for two years.In this period she successfully expanded the late phase client base and gained critical experience understanding clients’ needs in late phase clinical services. Zeliha has also experience in setting up Clinical Trials and Scientific Networks. She has set up and managed several Late Phase Clinical Stem Cell trials, and has setup a Cardiovascular Stem Cell network, where pharma &biotech companies, regulatory organizations, and academics together discussed the hurdles in the Cardiac Stem Cell field.Zeliha earned her MSc degree at the University of Utrecht where she studied Biomedical Sciences. Zeliha also has a B.A. background from the Nyenrode Business University from The Netherlands.